Home › Treatments › Oncology › Bosulif

Bosulif

Oncology

Manufacturer: Pfizer Limited
Salt Composition: bosutinib
Pack Size: 28 tablets x 100 mg
Prescription Required

Introduction

Bosulif (bosutinib) is a medication used for the treatment of chronic myeloid leukaemia (CML) in adults with the Philadelphia chromosome (Ph+).

It is used to treat adult patients with newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML) or with chronic, accelerated, or blast phase Ph+ CML with resistance or intolerance to prior therapy.

Safety Advice

Pregnancy: Consult Doctor

Lungs: Consult Doctor

Breastfeeding: Consult Doctor

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.